Skip to main content
Clinical Trials/NCT00953992
NCT00953992
Completed
Not Applicable

The Study of Etiology, Epidemiology and Prognostic Factors of Acute Kidney Injury

Huashan Hospital1 site in 1 country651 target enrollmentApril 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Renal Failure
Sponsor
Huashan Hospital
Enrollment
651
Locations
1
Primary Endpoint
renal function survival rate days in the hospital days in the ICU
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

  • To investigate the etiology, epidemiology and prognostic factors of acute kidney injury.
  • To find out risk factors that relate with the prognosis of acute kidney injury,focusing on inflammation, oxidative stress and nutritional status.
  • To study on the relationship between gene polymorphism and prognosis of acute kidney injury.

Detailed Description

1. to investigate the relationship between preexisting malnutrition and adverse outcomes in patients with AKI - Several nutritional assessment methods such as anthropometric, clinical and biochemical evaluations have been used; however, no single indicator is considered to be a "gold standard." 2. to evaluate the association of serum nutritional variables and prognosis of acute kidney injury 3. Given the different half-lives of serum nutritional markers, we hypothesized that the utility of serum nutritional variables as prognostic predictors may differ in early death (\<7 days) and late death (\>7 days, \<28 days) patients.

Registry
clinicaltrials.gov
Start Date
April 2009
End Date
May 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Feng Ding,MD

professor

Huashan Hospital

Eligibility Criteria

Inclusion Criteria

  • age \>=16 years and \<= 88 years
  • clinically diagnosed with acute kidney injury, according RIFLE or KDIGO criteria.

Exclusion Criteria

  • acute Renal Failure occurring in the setting of burns, obstructive uropathy, allergic interstitial nephritis, acute or rapidly progressive glomerulonephritis, vasculitis, hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura (TTP), malignant hypertension, scleroderma renal crisis, atheroembolism, functional or surgical nephrectomy, hepatorenal syndrome, cyclosporin or tacrolimus nephrotoxicity
  • Do Not Resuscitate (DNR) status
  • subjects enrolled in another clinical trial that could affect the outcome of this study protocol

Outcomes

Primary Outcomes

renal function survival rate days in the hospital days in the ICU

Time Frame: discharg from hospital, 28days,90days

Study Sites (1)

Loading locations...

Similar Trials